Cipla's wholly owned subsidiary -- Cipla Medpro South Africa (Pty) has completed closing of transaction and acquired 30% stake in Brandmed (Pty). Out of the total upfront cash consideration payment of ZAR 65 million, ZAR 50 million has been paid and balance will be paid over a period of next 12 months.
Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. The company’s portfolio includes over 1500 products across wide range of therapeutic categories with one quality standard globally.
